Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study

Abutalebi J, Rosa PAD, Castro Gonzaga AK, Keim R, Costa A, Perani D (2013) The role of the left putamen in multilingual language production. Brain Lang 125:307–315. https://doi.org/10.1016/j.bandl.2012.03.009

Article  PubMed  Google Scholar 

Arnold C, Gehrig J, Gispert S, Seifried C, Kell CA (2014) Pathomechanisms and compensatory efforts related to Parkinsonian speech. NeuroImage Clin 4:82–97. https://doi.org/10.1016/j.nicl.2013.10.016

Article  PubMed  Google Scholar 

Berankova D, Janousova E, Mrackova M, Eliasova I, Kostalova M, Skutilova S, Rektorova I (2015) Addenbrooke’s cognitive examination and individual domain cut-off scores for discriminating between different cognitive subtypes of Parkinson’s disease. Parkinson Dis 2015:579417. https://doi.org/10.1155/2015/579417

Article  Google Scholar 

Brabenec L, Mekyska J, Galaz Z, Rektorova I (2017) Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation. J Neural Transm 124:303–334. https://doi.org/10.1007/s00702-017-1676-0

Article  CAS  PubMed  Google Scholar 

Brabenec L, Klobusiakova P, Barton M, Mekyska J, Galaz Z, Zvoncak V, Kiska T, Mucha J, Smekal Z, Kostalova M, Rektorova I (2019) Non-invasive stimulation of the auditory feedback area for improved articulation in Parkinson’s disease. Parkinsonism Relat Disord 61:187–192. https://doi.org/10.1016/j.parkreldis.2018.10.011

Article  PubMed  Google Scholar 

Brabenec L, Klobusiakova P, Simko P, Kostalova M, Mekyska J, Rektorova I (2021) Non-invasive brain stimulation for speech in Parkinson’s disease: a randomized controlled trial. Brain Stimul 14(3):571–578. https://doi.org/10.1016/j.brs.2021.03.010

Article  PubMed  Google Scholar 

Brown S, Laird AR, Pfordresher PQ, Thelen SM, Turkeltaub P, Liotti M (2009) The somatotopy of speech: phonation and articulation in the human motor cortex. Brain Cogn 70:31–41. https://doi.org/10.1016/j.bandc.2008.12.006

Article  PubMed  PubMed Central  Google Scholar 

Cushnie-Sparrow D, Adams S, Abeyesekera A, Pieterman M, Gilmore G, Jog M (2018) Voice quality severity and responsiveness to levodopa in Parkinson’s disease. J Commun Disord 76:1–10. https://doi.org/10.1016/j.jcomdis.2018.07.003

Article  PubMed  Google Scholar 

Elfmarková N, Gajdoš M, Mračková M, Mekyska J, Mikl M, Rektorová I (2016) Impact of Parkinson’s disease and levodopa on resting state functional connectivity related to speech prosody control. Parkinsonism Relat Disord 22:S52–S55. https://doi.org/10.1016/j.parkreldis.2015.09.006

Article  PubMed  Google Scholar 

Fritsch M, Rangus I, Nolte CH (2022) Thalamic Aphasia: a review. Curr Neurol Neurosci Rep 22:855–865. https://doi.org/10.1007/s11910-022-01242-2

Article  PubMed  PubMed Central  Google Scholar 

Frota S, Cruz M, Cardoso R, Guimarães I, Ferreira JJ, Pinto S, Vigário M (2021) (Dys)Prosody in Parkinson’s disease: effects of medication and disease duration on intonation and prosodic phrasing. Brain Sci. https://doi.org/10.3390/brainsci11081100

Article  PubMed  PubMed Central  Google Scholar 

Gago MF, Garrett MC, Fonseca MR, Rosas MJ, Simões MF, Vieira S, Botelho F (2009) How do cognitive and axial motor signs correlate in Parkinson’s disease? A 6-year prospective study. J Neurol 256:1655–1662. https://doi.org/10.1007/s00415-009-5174-7

Article  PubMed  Google Scholar 

Goberman AM, Blomgren M (2003) Parkinsonian speech disfluencies: effects of l-dopa-related fluctuations. J Fluen Disord 28:55–70. https://doi.org/10.1016/S0094-730X(03)00005-6

Article  Google Scholar 

Gómez-Vilda P, Mekyska J, Ferrández JM, Palacios-Alonso D, Gómez-Rodellar A, Rodellar-Biarge V, Galaz Z, Smekal Z, Eliasova I, Kostalova M, Rektorova I (2017) Parkinson disease detection from speech articulation neuromechanics. Front Neuroinform. https://doi.org/10.3389/fninf.2017.00056

Article  PubMed  PubMed Central  Google Scholar 

Jacquemot C, Bachoud-Lévi A-C (2021) Striatum and language processing: where do we stand? Spec Issue Honour Jacques Mehler Cogn Found Ed 213:104785. https://doi.org/10.1016/j.cognition.2021.104785

Article  Google Scholar 

Klobusiakova P, Mekyska J, Brabenec L, Galaz Z, Zvoncak V, Mucha J, Rapcsak SZ, Rektorova I (2021) Articulatory network reorganization in Parkinson’s disease as assessed by multimodal MRI and acoustic measures. Parkinsonism Relat Disord 84:122–128. https://doi.org/10.1016/j.parkreldis.2021.02.012

Article  PubMed  Google Scholar 

Klostermann F, Ehlen F (2013) Functional roles of the thalamus for language capacities. Front Syst Neurosci. https://doi.org/10.3389/fnsys.2013.00032

Article  PubMed  PubMed Central  Google Scholar 

Košálová M, Mráčková M, Mareček R, Beránková D, Eliášová I, Koritakova E, Roubíčková J, Bednarik J, Rektorové I (2013) The 3F test dysarthric profile—normative speach values in Czech. Ceska Slov Neurol Neurochir 76:614–618

Google Scholar 

Kulisevsky J, García-Sánchez C, Berthier ML, Barbanoj M, Pascual-Sedano B, Gironell A, Estévez-González A (2000) Chronic effects of dopaminergic replacement on cognitive function in Parkinson’s disease: a two-year follow-up study of previously untreated patients. Mov Disord 15:613–626. https://doi.org/10.1002/1531-8257(200007)15:4%3c613::AID-MDS1005%3e3.0.CO;2-F

Article  CAS  PubMed  Google Scholar 

Liotti M, Ramig LO, Vogel D (2003) Hypophonia in Parkinson’s disease: neural correlates of voice treatment revealed by PET. Neurology 60:432–440

Article  CAS  PubMed  Google Scholar 

Maillet A, Krainik A, Debû B, Troprès I, Lagrange C, Thobois S, Pollak P, Pinto S (2012) Levodopa effects on hand and speech movements in patients with Parkinson’s disease: a FMRI study. PLoS One 7:e46541–e46541. https://doi.org/10.1371/journal.pone.0046541

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manes JL, Tjaden K, Parrish T, Simuni T, Roberts A, Greenlee JD, Corcos DM, Kurani AS (2018) Altered resting-state functional connectivity of the putamen and internal globus pallidus is related to speech impairment in Parkinson’s disease. Brain Behav 8(9):e01073. https://doi.org/10.1002/brb3.1073

Article  PubMed  PubMed Central  Google Scholar 

Mekyska J, Janousova E, Gomez-Vilda P, Smekal Z, Rektorova I, Eliasova I, Kostalova M, Mrackova M, Alonso-Hernandez JB, Faundez-Zanuy M, López-de-Ipiña K (2015) Robust and complex approach of pathological speech signal analysis. Neurocomputing 167:94–111. https://doi.org/10.1016/j.neucom.2015.02.085

Article  Google Scholar 

Murphy E, Hoshi K, Benítez-Burraco A (2022) Subcortical syntax: reconsidering the neural dynamics of language. J Neurolinguist 62:101062. https://doi.org/10.1016/j.jneuroling.2022.101062

Article  Google Scholar 

New AB, Robin DA, Parkinson AL, Eickhoff CR, Reetz K, Hoffstaedter F, Mathys C, Sudmeyer M, Michely J, Caspers J, Grefkes C, Larson CR, Ramig LO, Fox PT, Eickhoff SB (2015) The intrinsic resting state voice network in Parkinson’s disease. Hum Brain Mapp 36:1951–1962. https://doi.org/10.1002/hbm.22748

Article  PubMed  PubMed Central  Google Scholar 

Nieoullon A (2002) Dopamine and the regulation of cognition and attention. Prog Neurobiol 67:53–83. https://doi.org/10.1016/S0301-0082(02)00011-4

Article  CAS  PubMed  Google Scholar 

Nutt JG, Carter JH, Van Houten L, Woodward WR (1997) Short- and long-duration responses to levodopa during the first year of levodopa therapy. Ann Neurol 42:349–355. https://doi.org/10.1002/ana.410420311

Article  CAS  PubMed  Google Scholar 

Pichon S, Kell CA (2013) Affective and sensorimotor components of emotional prosody generation. J Neurosci 33:1640. https://doi.org/10.1523/JNEUROSCI.3530-12.2013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rektorová I (2010) Effects of dopamine agonists on neuropsychiatric symptoms of Parkinson’s disease. Neurodegener Dis 7:206–209. https://doi.org/10.1159/000295665

Article  CAS  PubMed  Google Scholar 

Rektorová I, Rektor I, Bareš M, Dostál V, Ehler E, Fanfrdlová Z, Fiedler J, Klajblová H, Kulišt’ák P, Ressner P, Svátová J, Urbánek K, Velísková J (2005) Cognitive performance in people with Parkinson’s disease and mild or moderate depression: effects of dopamine agonists in an add-on to l-dopa therapy. Eur J Neurol 12:9–15. https://doi.org/10.1111/j.1468-1331.2004.00966.x

Article  PubMed  Google Scholar 

Rektorova I, Barrett J, Mikl M, Rektor I, Paus T (2007) Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson’s disease. Mov Disord 22:2043–2051. https://doi.org/10.1002/mds.21548

Article  PubMed  Google Scholar 

Rektorova I, Mekyska J, Janousova E, Kostalova M, Eliasova I, Mrackova M, Berankova D, Necasova T, Smekal Z, Marecek R (2016) Speech prosody impairment predicts cognitive decline in Parkinson’s disease. Parkinsonism Relat Disord 29:90–95. https://doi.org/10.1016/j.parkreldis.2016.05.018

Article  PubMed  Google Scholar 

Rusz J, Tykalová T, Klempíř J, Čmejla R, Růžička E (2016) Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: longitudinal follow-up study on previously untreated patients. J Neural Transm 123:379–387. https://doi.org/10.1007/s00702-016-1515-8

Article  CAS  PubMed  Google Scholar 

Rusz J, Tykalova T, Novotny M, Zogala D, Sonka K, Ruzicka E, Dusek P (2021) Defining speech subtypes in de novo Parkinson disease. Neurology 97:e2124. https://doi.org/10.1212/WNL.0000000000012878

Article  CAS  PubMed  Google Scholar 

Rusz J, Tykalová T, Novotný M, Zogala D, Růžička E, Dušek P (2022) Automated speech analysis in early untreated Parkinson’

Comments (0)

No login
gif